Publications by authors named "Pavlos Msaouel"

90Publications

Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.

Clin Genitourin Cancer 2020 Dec 2. Epub 2020 Dec 2.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Center for Precision Environmental Health, Baylor College of Medicine, Houston, TX. Electronic address:

View Article and Find Full Text PDF
December 2020

TAM kinase inhibition and immune checkpoint blockade- a winning combination in cancer treatment?

Expert Opin Ther Targets 2020 Dec 31:1-11. Epub 2020 Dec 31.

Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article and Find Full Text PDF
December 2020

Expression of IGF-IEc Isoform in Renal Cell Carcinoma Tissues.

Anticancer Res 2020 Nov;40(11):6213-6219

Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

View Article and Find Full Text PDF
November 2020

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye.

Mol Cell Oncol 2020 23;7(5):1777060. Epub 2020 Jun 23.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
June 2020

Causal Diagram Techniques for Urologic Oncology Research.

Clin Genitourin Cancer 2020 Aug 13. Epub 2020 Aug 13.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
August 2020

A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and death.

Stat Med 2020 Jul 7;39(15):2035-2050. Epub 2020 Apr 7.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
July 2020

Cancer Genetics and Therapeutic Opportunities in Urologic Practice.

Cancers (Basel) 2020 Mar 18;12(3). Epub 2020 Mar 18.

Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF
March 2020

Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.

Anticancer Res 2020 02;40(2):709-718

Department of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

View Article and Find Full Text PDF
February 2020

Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

Cancer Treat Res Commun 2020 Jan 3;23:100166. Epub 2020 Jan 3.

Department of Genitourinary Medical Oncology, Unit 1374, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX 77030-3721, USA. Electronic address:

View Article and Find Full Text PDF
January 2020

Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors.

Int J Gynecol Cancer 2020 01 1;30(1):89-93. Epub 2019 Dec 1.

Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article and Find Full Text PDF
January 2020